Johnson & Johnson
JNJ
$149.79
Share price
-0.62%
Change (1 day)
0.70%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Market capitalization of Johnson & Johnson (JNJ)
Market cap: $360.40 Billion USD
As of June 2025 Johnson & Johnson has a market cap of $360.40 Billion USD. This makes Johnson & Johnson the world's 23th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Johnson & Johnson from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $360.40 B | 3.2% |
| 2024 | $349.22 B | -7.45% |
| 2023 | $377.31 B | -18.3% |
| 2022 | $461.84 B | 2.55% |
| 2021 | $450.35 B | 8.7% |
| 2020 | $414.30 B | 7.89% |
| 2019 | $384.00 B | 11.77% |
| 2018 | $343.57 B | -8.47% |
| 2017 | $375.36 B | 19.76% |
| 2016 | $313.43 B | 10.28% |
| 2015 | $284.22 B | -2.34% |
| 2014 | $291.04 B | 12.66% |
| 2013 | $258.34 B | 32.64% |
| 2012 | $194.77 B | 8.76% |
| 2011 | $179.08 B | 5.44% |
| 2010 | $169.85 B | -4.42% |
| 2009 | $177.71 B | 7.05% |
| 2008 | $166.00 B | -12.37% |
| 2007 | $189.44 B | -0.82% |
| 2006 | $191.01 B | 6.85% |
| 2005 | $178.76 B | -5.12% |
| 2004 | $188.42 B | 22.89% |
| 2003 | $153.32 B | -3.83% |
| 2002 | $159.42 B | -11.47% |
| 2001 | $180.09 B | 23.23% |
| 2000 | $146.13 B | 12.77% |
| 1999 | $129.58 B | 14.95% |
| 1998 | $112.73 B | 27.22% |
| 1997 | $88.61 B | 33.67% |
| 1996 | $66.29 B |
End of Day market cap according to different sources
On Jun 21st, 2025 the market cap of Johnson & Johnson was reported to be:
$360.40 Billion USD
$360.40 Billion USD
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $136.27 B | -62.19% | 🇺🇸 USA |
 Merck MRK | $198.52 B | -44.92% | 🇺🇸 USA |
 Novartis NVS | $229.52 B | -36.31% | 🇨🇭 Switzerland |
 Sanofi SNY | $116.54 B | -67.66% | 🇫🇷 France |
 Stryker Corporation SYK | $143.52 B | -60.18% | 🇺🇸 USA |
 Medtronic MDT | $110.68 B | -69.29% | 🇮🇪 Ireland |
 Eli Lilly LLY | $684.73 B | 89.99% | 🇺🇸 USA |
 Abbott Laboratories ABT | $231.38 B | -35.80% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $77.95 B | -78.37% | 🇬🇧 UK |
 Gilead Sciences GILD | $134.96 B | -62.55% | 🇺🇸 USA |